Enrichment with anti-cytokeratin alone or combined with anti-EpCAM antibodies significantly increases the sensitivity for circulating tumor cell detection in metastatic breast cancer patients.

Source:http://linkedlifedata.com/resource/pubmed/id/18687126

Download in:

View as

General Info

PMID
18687126